Clinical trialNCT03817099UnknownInterventional

Malaysia Diabetes Ramadan Nutrition Plan (My Dia-RNP®): A Feasibility Study

SponsorUniversiti Putra MalaysiaEnrollment53Type 2 Diabetes Mellitus

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Ramadan fasting is an important event for Muslims. During Ramadan, all healthy Muslims are asked to abstain from food and drink throughout the day and eat only during daybreak (also know as Sahur in Malay/Arabic language) and after sunset (also know as Iftar in Malay/Arabic language). Patients with type 2 diabetes (T2DM) can be exempted from fasting but most of them do not perceive themselves as sick, and they continue to fast. With so many Muslims with diabetes choosing to fast, there is an immediate need for evidence-based nutrition practice guidelines. This study is conducted to determine the feasibility of implementing the Ramadan Nutrition Plan named My Dia-RNP that is also incorporating diabetes-specific nutrition formula on dietary adherence and acceptability in patients with type 2 diabetes mellitus. We hypothesized that My Dia-RNP is feasible to be practiced by patients with type 2 diabetes.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Azrina Azlan, PhD
Universiti Putra Malaysia
Principal Investigator
clinicaltrials.gov ↗
Barakatun-Nisak Mohd Yusof, PhD
Universiti Putra Malaysia
Principal Investigator
clinicaltrials.gov ↗
Firdaus Mamat @ Mukhtar, PhD
Universiti Putra Malaysia
Principal Investigator
clinicaltrials.gov ↗
Nor Farahain Yahya, Degree
Universiti Putra Malaysia
Principal Investigator
clinicaltrials.gov ↗
Noraida Omar, PhD
Universiti Putra Malaysia
Principal Investigator
clinicaltrials.gov ↗
Norhasmah Sulaiman, PhD
Universiti Putra Malaysia
Principal Investigator
clinicaltrials.gov ↗
Nur Maziah Hanum Osman, Master
Universiti Putra Malaysia
Principal Investigator
clinicaltrials.gov ↗
Osama Hamdy, MD, PhD
Joslin Diabetes Centre
Principal Investigator
clinicaltrials.gov ↗
Siti NurA'syura Adznam, PhD
Universiti Putra Malaysia
Principal Investigator
clinicaltrials.gov ↗
Wan Zul Haikal Hafiz Wan Zukiman, Mmed
Universiti Putra Malaysia
Principal Investigator
clinicaltrials.gov ↗
Zalina Abu Zaid, PhD
Universiti Putra Malaysia
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Malaysia

Universiti Putra Malaysia
Serdang, Selangor, Malaysia
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Apr 2019
Primary completion: 1 Dec 2019
Completion: 30 Dec 2019
Last update posted: 12 Aug 2019
Registered enrollment: 53
Registry id: NCT03817099

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.